The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinician utilization of a plasma-only, multiomic minimal residual disease (MRD) assay in 2,000 consecutive patients with colorectal cancer (CRC).
 
Katrina Sophia Pedersen
Consulting or Advisory Role - Array BioPharma; Bayer; Novartis; Pfizer
Speakers' Bureau - Clinical Care Options; WebMD
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Ipsen (Inst); Merck (Inst); Natera (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; Nouscom
Other Relationship - UpToDate
(OPTIONAL) Uncompensated Relationships - NCCN
 
Leslie A. Bucheit
Employment - Guardant Health; Myriad Genetics
Stock and Other Ownership Interests - Guardant Health
 
Benjamin R. Tan
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); Roche/Genentech (Inst); TYME (Inst)
 
Zishuo Ian Hu
No Relationships to Disclose
 
Michael Shusterman
No Relationships to Disclose
 
Caroline Weipert
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health